Recombinant Tragelaphus oryx Ribonuclease pancreatic (RNASE1)

Shipped with Ice Packs
In Stock

Description

Definition and Context

Recombinant Tragelaphus oryx Ribonuclease pancreatic (RNASE1) refers to a laboratory-engineered version of the ribonuclease enzyme naturally produced in the pancreas of the common eland. RNASE1 enzymes are part of the RNase A superfamily, characterized by their ability to hydrolyze RNA substrates. In other species, such as humans (Homo sapiens) and bovines (Bos taurus), recombinant RNASE1 has been studied for applications in cancer therapy, molecular biology, and biotechnology .

2.2. Production and Purification

Recombinant RNASE1 proteins are typically produced in prokaryotic (e.g., E. coli) or eukaryotic (e.g., HEK293) systems, followed by refolding and chromatography-based purification . For example:

Host SystemYield (mg/L)Purity (%)Activity (Units/mg)
E. coli BL218–12>901.5–2.5 × 10⁶
HEK293 Cells3–5>953–4 × 10⁶

No analogous data exist for Tragelaphus oryx RNASE1.

3.1. Ribonucleolytic Activity

Human and bovine RNASE1 exhibit:

  • Substrate Specificity: Cleaves single-stranded RNA after pyrimidine residues (C/U) .

  • Catalytic Mechanism: Two-step hydrolysis via a 2',3'-cyclic phosphate intermediate .

  • Inhibition: Suppressed by placental ribonuclease inhibitor (RI) through tight binding (Kₐ ≈ 10⁻¹⁶ M) .

3.2. Therapeutic Potential

Engineered RNASE1 variants from humans show cytotoxic effects against cancer cells:

VariantIC₅₀ (μM)Target SpecificityMechanism
GnRH-hpRNASE1 0.32GnRH receptor+ cellsApoptosis induction
Tat-hpRNASE1 0.55Broad cell penetrationNon-specific RNA cleavage

These findings highlight the potential for species-specific RNASE1 engineering, but no analogous studies exist for Tragelaphus oryx.

Critical Data Gaps

  • Sequence Data: No genomic or transcriptomic records for Tragelaphus oryx RNASE1 are available in NCBI or UniProt.

  • Functional Studies: Absence of cytotoxicity, enzymatic kinetics, or structural analyses.

  • Commercial Availability: Listed as a product by some suppliers (e.g., ), but technical specifications (e.g., activity, purity) are undisclosed.

Recommendations for Future Research

  1. Transcriptome Sequencing: Prioritize RNA sequencing of Tragelaphus oryx pancreatic tissue to identify the native RNASE1 sequence.

  2. Comparative Modeling: Use AlphaFold2 or RoseTTAFold to predict 3D structure based on homologous sequences.

  3. Activity Profiling: Assess substrate preferences, inhibitor sensitivity, and thermal stability using standardized assays .

Product Specs

Form
Lyophilized powder. We will ship the format we have in stock. If you have special format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult your local distributor for specific delivery times. All proteins are shipped with normal blue ice packs by default. Request dry ice shipment in advance (extra fees apply).
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer ingredients, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you have a specific tag type requirement, please inform us for prioritized development.
Synonyms
RNASE1; RNS1; Ribonuclease pancreatic; EC 4.6.1.18; RNase 1; RNase A
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-124
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Tragelaphus oryx (Eland) (Taurotragus oryx)
Target Names
RNASE1
Target Protein Sequence
KETAAAKFER QHMDSSTSSA SSSNYCNQMM KSRDMTKDRC KPVNTFVHZS LABVZAVCSZ KBVACKBGZT BCYZSYSTMS ITBCRZTGSS KYPBCAYKTT ZAZKHIIVAC ZGBPYVPVHF BASV
Uniprot No.

Target Background

Function
Endonuclease that cleaves RNA on the 3' side of pyrimidine nucleotides. Acts on single-stranded and double-stranded RNA.
Protein Families
Pancreatic ribonuclease family
Subcellular Location
Secreted.
Tissue Specificity
Pancreas.

Q&A

What is Tragelaphus oryx RNASE1 and what is its biological significance?

Tragelaphus oryx (eland) pancreatic ribonuclease (RNASE1) is a member of the ribonuclease A superfamily that primarily functions in the digestive system to break down dietary RNA. In ruminants like eland, RNASE1 may have evolved specialized functions related to their unique digestive physiology, potentially processing RNA from symbiotic microorganisms in the rumen. The enzyme catalyzes the cleavage of RNA by hydrolyzing phosphodiester bonds, typically on the 3' side of pyrimidine nucleotides.

Evolutionary studies reveal that RNASE1 in artiodactyls (even-toed ungulates) shows interesting patterns of functional diversification. While Tragelaphus oryx expresses pancreatic RNASE1, other related bovids have evolved specialized seminal RNases derived from pancreatic RNase genes, representing a classic example of protein functional recruitment during evolution .

How does Tragelaphus oryx RNASE1 compare structurally and functionally to other mammalian pancreatic ribonucleases?

Tragelaphus oryx RNASE1 shares significant sequence homology with other mammalian pancreatic ribonucleases, particularly those from related artiodactyls. The protein likely maintains the conserved catalytic triad (His12, His119, Lys41 in the bovine RNase A numbering system) essential for activity. Specific amino acid differences can significantly alter catalytic properties - research on ancestral RNase reconstruction has shown that even single amino acid substitutions at critical positions (such as position 38) can dramatically change catalytic activity against duplex RNA .

Importantly, unlike some bovids like Bos taurus (cattle) that express both pancreatic and seminal RNases, Tragelaphus oryx appears to primarily express the pancreatic form. This is similar to the pattern seen in Ovis (sheep and goats), where RNase in seminal plasma derives from the pancreatic gene rather than a specialized seminal variant .

What evolutionary insights has Tragelaphus oryx RNASE1 research provided?

Tragelaphus oryx RNASE1 has contributed to our understanding of protein evolution and functional diversification in artiodactyls. Research including eland RNase has revealed:

  • The timing and pattern of gene duplication events that led to specialized seminal RNases in some artiodactyl lineages but not others

  • Evidence of differential selective pressures on pancreatic versus seminal RNases

  • Examples of how protein recruitment can lead to novel functions during evolution

The examination of seminal plasma from multiple artiodactyls, including Tragelaphus oryx, helped establish that only certain bovid lineages (primarily Bovinae) express specialized seminal RNases, while others like Tragelaphus rely on pancreatic RNase . This pattern aligns with phylogenetic relationships and suggests the seminal RNase gene duplication occurred after the divergence of key artiodactyl lineages.

What expression systems are most effective for recombinant Tragelaphus oryx RNASE1?

For recombinant expression of Tragelaphus oryx RNASE1, several systems can be employed, each with advantages and limitations:

Expression SystemAdvantagesLimitationsRecommendations
E. coliHigh yield, cost-effective, rapid growthRisk of endogenous RNase contamination, improper foldingUse BL21(DE3) RNase-deficient strains; add purification tags; optimize codon usage
Yeast (P. pastoris)Better protein folding, secretion capacityLower yields, longer processConsider for difficult-to-fold variants; use α-factor signal sequence
Mammalian cellsNative-like post-translational modificationsHigher cost, technical complexityUseful if glycosylation is critical; HEK293 or CHO cells
Cell-free systemsAvoids contamination issuesLower yield, higher costConsider for preliminary analysis or problematic constructs

The critical concern with E. coli expression is contamination with host RNases that can co-purify with the target protein . This is particularly relevant when subsequent activity assays might misattribute RNase activity to the recombinant protein when it actually comes from contaminants.

How can I verify the purity of recombinant Tragelaphus oryx RNASE1?

Verifying purity of recombinant Tragelaphus oryx RNASE1 requires multiple complementary approaches:

  • SDS-PAGE analysis with silver staining (more sensitive than Coomassie blue)

  • Western blotting with anti-RNASE1 antibodies

  • Mass spectrometry analysis to identify potential contaminating proteins

  • Size-exclusion chromatography to evaluate homogeneity

  • Zymogram analysis using RNA-containing gels to detect RNase activity

Research on recombinant PR-10 proteins has demonstrated that standard purity assessments can miss low-level contaminating RNases that nonetheless contribute significant activity . Heat inactivation controls may be insufficient because some contaminating RNases might have similar thermal stability profiles to the target protein.

What are common contaminants in recombinant RNASE1 preparations and how can they be eliminated?

Based on published research, the most concerning contaminants in recombinant RNASE1 preparations are:

  • Host ribonucleases that co-purify with the target protein

  • Endotoxins (lipopolysaccharides) from E. coli cell walls

  • Chaperone proteins that associate with recombinant proteins during folding

  • Nucleic acids (DNA/RNA fragments)

Studies investigating recombinant PR-10 proteins revealed that E. coli RNases can contaminate purified recombinant proteins and lead to false attribution of ribonuclease activity . These contaminating RNases may persist through standard purification protocols and remain active even at very low concentrations.

Effective elimination strategies include:

  • Multi-step purification combining different principles (affinity, ion-exchange, size exclusion)

  • RNase inhibitor treatment during initial purification steps

  • Polymyxin B treatment to remove endotoxins

  • Thermal treatment under controlled conditions if the target protein is more stable than contaminants

  • Inclusion of negative control proteins purified under identical conditions to identify contamination issues

What are reliable methods to assess ribonuclease activity of recombinant Tragelaphus oryx RNASE1?

Reliable assessment of recombinant Tragelaphus oryx RNASE1 activity requires multiple complementary approaches:

MethodPrincipleAdvantagesLimitations
Gel-based RNA degradationVisualizing RNA digestion on agarose gelsSimple, visual confirmationSemi-quantitative, can miss subtle effects
Spectrophotometric assaysMeasuring hyperchromicity during RNA hydrolysisQuantitative, real-time measurementLess sensitive to low activity levels
Fluorescence-based assaysUsing labeled RNA with fluorescence quenchingHigh sensitivity, quantitativeRequires specialized substrates
HPLC analysisAnalyzing nucleotide productsDetailed characterization of cleavage productsEquipment-intensive, complex analysis
ZymographyActivity detection in polyacrylamide gelsCan detect multiple active speciesSemi-quantitative

How can I distinguish between intrinsic RNase activity and contaminating RNases?

Distinguishing between intrinsic RNase activity of Tragelaphus oryx RNASE1 and activity from contaminating RNases requires rigorous experimental design:

  • Include negative control proteins with no expected RNase activity but purified under identical conditions

  • Perform site-directed mutagenesis on catalytic residues (His12, His119, Lys41) to create variants that should lack activity

  • Use specific RNase inhibitors (human placental RNase inhibitor affects mammalian RNases differently than bacterial ones)

  • Analyze activity under various conditions (pH, salt concentration) that differentially affect mammalian versus bacterial RNases

  • Use mass spectrometry to identify potential contaminating RNases

Research has shown that at least nine published reports on ribonuclease activity in plant PR-10 proteins lacked crucial control proteins, potentially leading to misattribution of activity from contaminating E. coli RNases to the recombinant proteins . Traditional controls such as heat inactivation may be insufficient if the contaminating RNases have similar stability profiles.

What controls are essential when analyzing ribonuclease activity in recombinant protein preparations?

Based on recent methodological insights, comprehensive controls for ribonuclease activity analysis should include:

  • Negative control proteins - proteins without expected RNase activity but expressed and purified identically

  • Catalytic site mutants that should lack activity if the observed effect is truly from the target protein

  • Commercial RNases (RNase A, T1) as positive controls with known activity profiles

  • Heat-inactivation controls, with awareness of their limitations

  • RNase inhibitor controls (human placental RNase inhibitor or DEPC treatment)

  • Buffer-only controls to check for environmental contamination

  • Time-course experiments to characterize degradation patterns

Research on PR-10 proteins revealed that traditional controls like heat inactivation can be misleading because they don't account for contaminating RNases that may have similar thermal stability profiles to the target protein . The crucial control is a negative control protein produced under identical conditions.

What structural features are critical for Tragelaphus oryx RNASE1 activity and stability?

While specific structural data for Tragelaphus oryx RNASE1 isn't provided in the available research, insights can be drawn from related mammalian ribonucleases:

  • Catalytic triad: His12, His119, and Lys41 (in bovine RNase A numbering) form the active site and are essential for catalytic activity

  • Disulfide bonds: Typically four disulfide bridges that maintain tertiary structure and stability

  • Substrate binding site: The P1 binding pocket determines nucleotide specificity

  • Position 38: Research on ancestral RNase reconstruction has shown that substitution at position 38 (Asp vs Gly) dramatically affects catalytic activity against duplex RNA

The stability of mammalian pancreatic RNases typically derives from their compact structure and disulfide bond network. This likely applies to Tragelaphus oryx RNASE1 as well, making it resistant to denaturation and proteolysis under physiological conditions.

How does substrate specificity of Tragelaphus oryx RNASE1 compare to other RNases?

Different ribonucleases exhibit distinct substrate preferences:

RibonucleasePrimary SpecificityNotable Characteristics
RNase A (Pancreatic)Cleaves after pyrimidines (C, U)Preference for single-stranded RNA
RNase T1Cleaves after guanines (G)Only cuts at G residues regardless of context
RNase IBroad specificityYields narrower distribution of footprints (28 nt)
RNase S7 (Micrococcal)Broad specificityYields broader distribution of footprints

While specific data on Tragelaphus oryx RNASE1 isn't available in the search results, as a pancreatic RNase, it likely shares substrate preferences with other mammalian pancreatic RNases, particularly preference for single-stranded RNA with specific cleavage after pyrimidines. Research on ribonuclease footprinting has shown that different RNases produce distinct patterns of RNA cleavage, which can significantly impact experimental outcomes in applications like ribosome profiling .

How do different experimental conditions affect Tragelaphus oryx RNASE1 activity?

Various experimental factors impact ribonuclease activity and should be optimized:

  • pH: Pancreatic RNases typically show optimal activity around pH 7.5-8.0

  • Ionic strength: Salt concentration affects substrate binding and catalytic efficiency

  • Temperature: Mammalian RNases are generally stable at physiological temperatures

  • Divalent cations: Magnesium and other divalent cations can modulate activity

  • Buffer composition: Different buffers can affect protein stability and activity

Research comparing ribonuclease behavior across species has shown that optimal conditions vary significantly. For example, RNase I performed well with yeast ribosomes but was ineffective with bacterial samples and degraded mouse ribosomes . This highlights the importance of optimizing experimental conditions specifically for Tragelaphus oryx RNASE1 rather than assuming conditions optimal for other RNases will be appropriate.

How can Tragelaphus oryx RNASE1 be used in evolutionary studies?

Tragelaphus oryx RNASE1 provides valuable opportunities for evolutionary research:

  • Ancestral sequence reconstruction: Following methods used in artiodactyl RNase studies, researchers can synthesize and characterize predicted ancestral sequences to understand functional evolution

  • Comparative enzyme kinetics: Analyzing catalytic parameters across species can reveal evolutionary adaptations

  • Positive selection analysis: Identifying sites under positive selection can highlight functionally important residues

  • Structure-function relationship studies: Examining how specific amino acid changes between species affect catalytic properties

The evolutionary relationship between pancreatic and seminal RNases in artiodactyls represents a classic example of protein functional diversification. Research examining RNase evolution across artiodactyls, including Tragelaphus oryx, revealed that seminal RNase genes experienced a unique evolutionary history in certain lineages, with some becoming non-functional pseudogenes while others evolved novel functions .

What methodological challenges exist in recombinant RNASE1 research and how can they be overcome?

Research with recombinant ribonucleases presents several methodological challenges:

  • RNase contamination: Host RNases can co-purify with the target protein, leading to false-positive activity results

  • Expression and folding: Disulfide-rich proteins like RNases can be difficult to express in their correctly folded form

  • Activity assay specificity: Distinguishing between different modes of RNA cleavage requires specialized assays

  • Substrate design: Creating appropriate RNA substrates for specific research questions

Recent research has highlighted the critical importance of proper controls when working with recombinant RNases. Studies on PR-10 proteins demonstrated that many published papers claiming ribonuclease activity may have attributed activity from contaminating E. coli RNases to the recombinant proteins .

To overcome these challenges:

  • Use multiple purification steps and rigorous purity assessment

  • Include appropriate control proteins purified under identical conditions

  • Employ catalytic site mutants to confirm activity mechanism

  • Design substrate RNAs that can distinguish between different cleavage specificities

  • Consider alternative expression systems less prone to RNase contamination

How can sequence-function relationships in Tragelaphus oryx RNASE1 inform protein engineering studies?

Understanding sequence-function relationships in Tragelaphus oryx RNASE1 can guide protein engineering efforts:

  • Catalytic efficiency: Research on ancestral RNase reconstruction has shown that single amino acid substitutions (such as at position 38) can dramatically alter catalytic activity against different RNA substrates

  • Stability engineering: The naturally high stability of mammalian RNases makes them excellent scaffolds for protein engineering

  • Substrate specificity: Modifications to the binding pocket can alter nucleotide preferences

  • Novel functions: The evolutionary history of artiodactyl RNases demonstrates how related proteins can evolve diverse functions

Ancestral sequence reconstruction studies of RNases revealed that the variant of ancestor "h1" that restores Asp at position 38 has catalytic activity against duplex RNA similar to RNase A, while variants with Gly at position 38 show reduced activity against duplex substrates . This demonstrates how single amino acid changes can significantly alter functional properties - a principle that can be exploited in protein engineering.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.